Can the Monocyte/HDL Ratio be used as A Marker to Predict Fatty Liver and Its Stages?

Journal Title: Journal of European Internal Medicine Professionals (JEIMP) - Year 2023, Vol 1, Issue 3

Abstract

Background: Our study aims to determine whether the monocyte/HDL ratio is a marker that can be used to predict the presence and stage of non-alcoholic fatty liver. Material and Method: Patients aged 18-65 years without known chronic diseases and medication use who applied to our hospital for a check-up were included in the study. Patients were divided into 4 groups based on ultrasonography findings: those without hepatosteatosis, those with stage 1, stage 2, and stage 3 hepatosteatosis. Groups were compared in terms of fasting glucose, insulin resistance, lipid profile, liver function tests, monocyte/HDL ratios. Results: Fasting glucose, insulin resistance, total cholesterol, LDL cholesterol, triglycerides, alanine aminotransferase, monocytes, and monocyte/HDL ratio were significantly higher in the group with hepatosteatosis than in the group without hepatosteatosis, and this increase was directly proportional to the stage. HDL was significantly lower in the hepatosteatosis group than in the group without hepatosteatosis, and HDL decreased further as the stage of hepatosteatosis increased. No difference was found between the groups in terms of aspartate aminotransferase. Multivariate regression analyses revealed that hepatosteatosis was independently associated with alanine aminotransferase, insulin resistance, and monocyte/HDL ratio. Conclusion: Monocyte/HDL ratio can be considered a simple, easily accessible, and inexpensive marker to predict the presence and stages of hepatosteatosis.

Authors and Affiliations

Ece Yiğit, İlknur Sayar

Keywords

Related Articles

Gestational Diabetes Mellitus

Gestational diabetes mellitus (GDM) refers to the onset of diabetes occurring after the conclusion of the first trimester of pregnancy. GDM is currently one of the most common pregnancy-related medical complications an...

The Effect of Hot Pepper, Sumac, and Chewing on Gastric inhibitory peptide, Glucagon-like Peptide, and Cholecystokinin Hormone Secretion

Background: The influence of various dietary factors on metabolic responses and gastrointestinal function has been the subject of extensive research. In this study, we aimed to investigate the effects of capsaicin, chewi...

Prognostic Value of Systemic Immune Inflammation Index in Malignant Ischemic Stroke: A Study on Patient Selection and Timing of Surgical Decompression

Background: Ischemic stroke is a substantial health concern with long-term neurological consequences and economic implications. Inflammation worsens secondary brain injury, prompting the search for prognostic biomarkers....

Comparison of Peritoneal Catheter Insertion Techniques: A Single-Center Experience Comparing Percutaneous and Laparoscopic Approaches

Background: There is still no consensus on the best approach for the insertion of the peritoneal dialysis catheter. We aimed to compare the results of the percutaneous Sildenger and laparoscopic surgical peritoneal dialy...

Musculoskeletal and Neurological Examination Findings in Post-COVID-19

Background: This study investigated the musculoskeletal and neurological examination findings in symptomatic patients who had previously experienced COVID-19. Material and Methods: A prospective cohort of 101 patients...

Download PDF file
  • EP ID EP719135
  • DOI https://doi.org/10.5281/zenodo.8134906
  • Views 54
  • Downloads 0

How To Cite

Ece Yiğit, İlknur Sayar (2023). Can the Monocyte/HDL Ratio be used as A Marker to Predict Fatty Liver and Its Stages?. Journal of European Internal Medicine Professionals (JEIMP), 1(3), -. https://europub.co.uk/articles/-A-719135